Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients

Clinical trial NCT00284687 · COMPLETED

Trial details

NCT number: NCT00284687
Sponsor: Hadassah Medical Organization
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2006-07-01
Primary completion: 2010-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.